The company is described as an established medical device titan expanding into the promising field of robotic surgery. It is highlighted as a 'sleeper stock' with the potential to surge before gaining broader attention from Wall Street. The news positions the firm as a key example in the robotic surgery space, suggesting it is on a promising new growth trajectory.